1. Metropolis Healthcare: 

Emkay maintains its ‘Buy’ rating on this diagnostic services provider, with a target price of Rs 675, an upside of 15.9%. Analysts Anshul Agrawal and Vivek Sethia remain optimistic after management confirmed its FY27 revenue growth guidance of 14–15%. Since the company plans no price hikes, higher testing volumes will be the key driver.

Metropolis plans to expand its owned diagnostic centres from 750 to 1,000. It also expects TruHealth, its preventive health-check brand, to increase contribution to 25% of revenue within three years, up from 18%. Addition of radiology and consultation to existing wellness packages will support this goal. The company is also focusing on specialised oncology and genetics tests, aiming to raise its revenue contribution by 500 bps to 45%. 

Agrawal and Sethia expect preventive testing, specialty diagnostics, and expansion into smaller cities to drive revenue visibility. Online channels already contribute 25% of revenue, while customers acquired digitally generate nearly twice the lifetime value of offline customers, supporting stronger long-term performance. Finally, a net cash position of Rs 180 crore allows Metropolis to fund acquisitions and network expansion without taking on heavy debt.

2. LG Electronics: 

Ventura maintains its ‘Buy’ call on this consumer electronics manufacturer, with a target price of Rs 2,141, an upside of 28.5%. LG Electronics is expected to benefit from rising sales of air conditioners, refrigerators, washing machines and TVs as more customers shift towards premium products. The company is also expanding beyond household appliances by supplying cooling systems to data centres.

Analysts anticipate demand to improve as easier access to consumer loans, higher urban incomes and better affordability encourage more people to buy appliances. LG’s wide range of products allows it to cater to both budget and premium customers. Data centres are another growth opportunity, as they require large cooling systems to keep servers running efficiently. Rising investment in AI and data centres will increase demand for LG’s energy-efficient cooling equipment.

LG’s manufacturing scale and deep distribution network will drive capacity utilisation and earnings improvement. Its Rs 5,000 crore Sri City compressor manufacturing plant in Andhra Pradesh will localise procurement and ramp up exports. Additionally, recurring revenue streams from maintenance contracts will provide long-term revenue and profitability growth. Analysts expect the company to deliver revenue and net profit CAGRs of 13.3% and 21.5%, respectively, over FY27-29.

3. Global Health: 

Prabhudas Lilladher reiterates its ‘Buy’ rating on this hospital chain, with a target price of Rs 1,750 per share, a 20% upside. Analysts Param Desai and Sanketa Kohale believe profit growth will pick up as operational issues at the Lucknow hospital ease and the newer Noida hospital treats more patients. They estimate EBITDA to rise at a 24% CAGR over FY27-29, compared with just 7% over FY24-26.

Global Health operates six hospitals with around 3,737 beds and plans to almost double the bed count over the next three to four years. Near-term improvement will come from existing hospitals and around 418 additional beds across Indore, Lucknow, Noida and Patna. Analysts project healthy revenue growth in FY27, supported by efficient clinical operations and a strong hospital network across North and East India.

Desai and Kohale highlight that the Noida unit will capture the underpenetrated NCR market with minimal capital expenditure, helped by new insurance approvals. They anticipate expansions in Indore, Noida, Lucknow, and Patna to become profitable in the next two to three quarters, while Ranchi should benefit from a higher volume of complex oncology cases. Analysts expect revenue to increase by around 16% annually and operating profit by 24% annually over FY27–29.

4. Oil India: 

ICICI Securities retains its ‘Buy’ rating on this oil & gas producer, with a target price of Rs 600, implying a 22.5% upside. Analysts Probal Sen and Hardik Solanki see strong momentum in both upstream and downstream segments. Oil production remains on track to reach 4 metric tonnes in FY27, while gas output should rise after FY28 expansion plans.

Oil India plans to boost long-term oil production over the next five to seven years. The company is preparing to start deepwater drilling in the Andaman and Mahanadi basins, helped by government incentives. Management projects gas production to grow 51.5% to 5 billion cubic meters by FY29, driven by the commissioning of Numaligarh Refinery, the Baghjan gas station, the Indradhanush Gas Grid, and the Duliajan Numaligarh Pipeline.

Sen and Solanki expect better oil realisations in FY27. They note that even if geopolitical conflicts in West Asia resolve, damaged infrastructure will delay supply normalisation, supporting higher oil prices. Meanwhile, demand lost during supply shortages should return once conditions improve, further supporting prices.

5. Prestige Estates Projects: 

Axis Direct maintains its ‘Buy’ rating on this real estate developer, with a target price of Rs 1,805, an upside of 15%. Analysts Eesha Shah and Vishal Jagwani remain positive on Prestige Estates as the company anticipates pre-sales to jump 15–20% in FY27. Growth is expected to be supported by new project launches in H2FY27 across Bengaluru, Chennai, Delhi-NCR, Mumbai and Hyderabad. Management notes that while regulatory delays held back some Q1 launches, underlying demand remains healthy. 

The company targets gross collections of Rs 25,000 crore in FY27, with up to 86% coming from residential sales. Prestige is also increasing its rental income through strong leasing demand at its commercial properties in Mumbai’s BKC and Mahalaxmi. The firm is developing a 100 MW data centre platform and may explore an IPO or strategic investment for its hospitality division.

Shah and Jagwani believe fast-paced launches, steady housing demand, and rising collections will drive growth through FY27. They expect strong cash generation to fund this expansion without adding significant debt, which could help net profit nearly double to Rs 2,567 crore by FY28.

Note: These recommendations are from various analysts and are not recommendations by Trendlyne.

(You can find all analyst picks here)